News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IVAX Corporation (IVX) Names New President Of IVAX Laboratories (IVX)



10/19/2005 5:08:50 PM

IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced today that Jesus Leal has joined IVAX' subsidiary, IVAX Laboratories, as President. IVAX Laboratories is a U.S. proprietary pharmaceuticals company that markets IVAX' current U.S. proprietary products such as prescription drugs for allergies, coughs and colds; Nasarel(R) for allergic rhinitis; and QVAR(R) for asthma; and is positioned to market the future products that emerge from IVAX' research pipeline. Mr. Leal will report to Neil Flanzraich, vice chairman and president, of IVAX Corporation.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES